DEA Reschedules Some CBD Products – A Milestone for Cannabis Medicine
DEA Reschedules Some CBD Products – A Milestone for Cannabis Medicine DEA Reschedules Some CBD Products – A Milestone for Cannabis Medicine In a landmark decision, the U.S. Drug Enforcement Administration (DEA) has shifted certain cannabidiol (CBD) products from the most restrictive category of controlled substances. This move paves the way for the sale of […]